Status:
COMPLETED
The Effect of Vitamin D Supplementation in Overweight and Obese Pregnant Women
Lead Sponsor:
KK Women's and Children's Hospital
Conditions:
Overweight and Obesity
Eligibility:
FEMALE
21-45 years
Phase:
NA
Brief Summary
To understand the role of vitamin D supplementation on pregnancy outcomes and metabolic status in overweight and obese pregnant women.
Detailed Description
The effects of vitamin D supplementation on pregnancy outcomes and metabolic status of overweight and obese pregnant women remain uncertain. In particular, the dosage of vitamin D supplementation has ...
Eligibility Criteria
Inclusion
- Gestation ≤16weeks (16 weeks + 6 days) upon intervention
- Pre-pregnancy BMI ≥25 kg/m2
- Aged 21-45 years
- Willing and able to provide written, informed consent
Exclusion
- Having current or past hypo/hyperparathyroidism, hypercalciuria, hypercalcemia or osteomalacia
- History of renal disease (including kidney stones and etc.), liver dysfunction, tuberculosis or sarcoidosis
- Pre-existing diabetes mellitus or chronic hypertension
- Taking lipid-lowering medicine
- Gestational diabetes (as confirmed by oral glucose tolerance test) or gestational hypertensive disorder
- Multiple pregnancy
Key Trial Info
Start Date :
May 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT04841265
Start Date
May 28 2021
End Date
March 31 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KK Women's and Children's Hospital
Singapore, Singapore